Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Jun 30, 2020

Provention Bio Announces Change to a Virtual Meeting Format for the 2020 Annual Meeting of the Stockholders
Jun 29, 2020

Provention Bio Announces Inclusion in the Russell 3000 Index and Russell 2000 Index
Jun 22, 2020

Provention Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Jun 19, 2020

FDA approves new Dupixent® (dupilumab) pre-filled pen designed to support more convenient self-administration

* Single-dose (300 mg) pre-filled pen provides additional administration option to adults and adolescents who are prescribed Dupixent
Jun 17, 2020

Provention Bio Announces Pricing of $95.7 Million Public Offering of Common Stock

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.